Cargando…
Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia
BACKGROUND: Coronary artery aneurysm (CAA) and coronary artery ectasia (CAE) may be two different types of coronary artery dilatation with unknown etiology. This study aimed to compare the differences between CAA and CAE and to investigate their pathogenesis and the necessity of antiplatelet therapy...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656333/ https://www.ncbi.nlm.nih.gov/pubmed/33209413 http://dx.doi.org/10.21037/jtd-20-1579 |
_version_ | 1783608359401816064 |
---|---|
author | Wei, Wei Wang, Xingxu Huang, Zhenghao Li, Xiaolin Luo, Yu |
author_facet | Wei, Wei Wang, Xingxu Huang, Zhenghao Li, Xiaolin Luo, Yu |
author_sort | Wei, Wei |
collection | PubMed |
description | BACKGROUND: Coronary artery aneurysm (CAA) and coronary artery ectasia (CAE) may be two different types of coronary artery dilatation with unknown etiology. This study aimed to compare the differences between CAA and CAE and to investigate their pathogenesis and the necessity of antiplatelet therapy. METHODS: One hundred patients each with confirmed CAA, CAE, and normal coronary artery (NCA) from September 2017 to July 2019 were included. All patients completed examinations of the ankle-brachial index (ABI), pulse wave rate, and carotid ultrasonography; and were tested for routine blood, lipid, and immune parameters. Blood samples were collected 1 week after the withdrawal of antiplatelet drugs, and vascular inflammatory indexes, platelet activation indexes, thromboelastography, and the platelet aggregation rate were measured. Analysis of variance and the chi-square or Fisher exact test were used for statistical analysis. RESULTS: The perinuclear anti-neutrophil cytoplasmic antibody (ANCA), endothelial-1, matrix metalloproteinase-9, and tumor necrosis factor-α were significantly higher in CAE than in NCA, while cytoplasmic ANCA was appreciably higher in CAE than in CAA (P<0.05). Myeloperoxidase and growth/differentiation factor-15 were significantly higher in CAE than in CAA and NCA (P<0.05). ABI was significantly lower in CAA and CAE than in NCA (P<0.05), low-density lipoprotein/high-density lipoprotein was significantly higher in CAA than in NCA (P<0.05), and the detection rate of carotid artery thickening was significantly higher in CAA than in CAE and NCA (P<0.05). The Gensini and SYNTAX scores were significantly higher in CAA than in CAE (P<0.05). The percentages of CD62P and PAC-1 were higher in CAA and CAE than in NCA (P<0.05). The arachidonic acid aggregation rate in CAA and adenosine 5'-diphosphate aggregation rate in CAE were significantly higher than in NCA (P<0.05). The values of thrombin formation time and reaction time were significantly lower in CAE than in NCA (P<0.05), and the α angle was significantly higher in CAE than in NCA. CONCLUSIONS: CAE was closely related to inflammation, whereas CAA was closely related to atherosclerosis. Platelet activation was present in both diseases; therefore, antiplatelet therapy is recommended. |
format | Online Article Text |
id | pubmed-7656333 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-76563332020-11-17 Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia Wei, Wei Wang, Xingxu Huang, Zhenghao Li, Xiaolin Luo, Yu J Thorac Dis Original Article BACKGROUND: Coronary artery aneurysm (CAA) and coronary artery ectasia (CAE) may be two different types of coronary artery dilatation with unknown etiology. This study aimed to compare the differences between CAA and CAE and to investigate their pathogenesis and the necessity of antiplatelet therapy. METHODS: One hundred patients each with confirmed CAA, CAE, and normal coronary artery (NCA) from September 2017 to July 2019 were included. All patients completed examinations of the ankle-brachial index (ABI), pulse wave rate, and carotid ultrasonography; and were tested for routine blood, lipid, and immune parameters. Blood samples were collected 1 week after the withdrawal of antiplatelet drugs, and vascular inflammatory indexes, platelet activation indexes, thromboelastography, and the platelet aggregation rate were measured. Analysis of variance and the chi-square or Fisher exact test were used for statistical analysis. RESULTS: The perinuclear anti-neutrophil cytoplasmic antibody (ANCA), endothelial-1, matrix metalloproteinase-9, and tumor necrosis factor-α were significantly higher in CAE than in NCA, while cytoplasmic ANCA was appreciably higher in CAE than in CAA (P<0.05). Myeloperoxidase and growth/differentiation factor-15 were significantly higher in CAE than in CAA and NCA (P<0.05). ABI was significantly lower in CAA and CAE than in NCA (P<0.05), low-density lipoprotein/high-density lipoprotein was significantly higher in CAA than in NCA (P<0.05), and the detection rate of carotid artery thickening was significantly higher in CAA than in CAE and NCA (P<0.05). The Gensini and SYNTAX scores were significantly higher in CAA than in CAE (P<0.05). The percentages of CD62P and PAC-1 were higher in CAA and CAE than in NCA (P<0.05). The arachidonic acid aggregation rate in CAA and adenosine 5'-diphosphate aggregation rate in CAE were significantly higher than in NCA (P<0.05). The values of thrombin formation time and reaction time were significantly lower in CAE than in NCA (P<0.05), and the α angle was significantly higher in CAE than in NCA. CONCLUSIONS: CAE was closely related to inflammation, whereas CAA was closely related to atherosclerosis. Platelet activation was present in both diseases; therefore, antiplatelet therapy is recommended. AME Publishing Company 2020-10 /pmc/articles/PMC7656333/ /pubmed/33209413 http://dx.doi.org/10.21037/jtd-20-1579 Text en 2020 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Wei, Wei Wang, Xingxu Huang, Zhenghao Li, Xiaolin Luo, Yu Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia |
title | Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia |
title_full | Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia |
title_fullStr | Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia |
title_full_unstemmed | Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia |
title_short | Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia |
title_sort | difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656333/ https://www.ncbi.nlm.nih.gov/pubmed/33209413 http://dx.doi.org/10.21037/jtd-20-1579 |
work_keys_str_mv | AT weiwei differenceininflammationatherosclerosisandplateletactivationbetweencoronaryarteryaneurysmandcoronaryarteryectasia AT wangxingxu differenceininflammationatherosclerosisandplateletactivationbetweencoronaryarteryaneurysmandcoronaryarteryectasia AT huangzhenghao differenceininflammationatherosclerosisandplateletactivationbetweencoronaryarteryaneurysmandcoronaryarteryectasia AT lixiaolin differenceininflammationatherosclerosisandplateletactivationbetweencoronaryarteryaneurysmandcoronaryarteryectasia AT luoyu differenceininflammationatherosclerosisandplateletactivationbetweencoronaryarteryaneurysmandcoronaryarteryectasia |